Inhibition of GSK 3β Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma

BACKGROUND: Enhancer of zeste homolog 2 (EZH2) has been shown to contribute to tumour development and/or progression. However, the signalling pathway underlying the regulation of EZH2 in nasopharyngeal carcinoma (NPC) remains unclear. Since EZH2 contains the putative Glycogen synthase kinase 3 beta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Renqiang, Wei, Yi, Huang, Xiaoming, Fu, Ran, Luo, Xi, Zhu, Xiaolin, Lei, Wenbin, Fang, Jugao, Li, Huabin, Wen, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715493/
https://www.ncbi.nlm.nih.gov/pubmed/23874688
http://dx.doi.org/10.1371/journal.pone.0068614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715493/
https://www.ncbi.nlm.nih.gov/pubmed/23874688
http://dx.doi.org/10.1371/journal.pone.0068614

Ejemplares similares